See the presentations of the 2018 Guatemala Sessions

SOLACI thanks the 210 attendees ─physicians, nurses, technicians and other professionals. Without them, we would not have achieved such scientific success at these regional sessions. We would also like to extend our appreciation to the Guatemalan Cardiology Association, to the organization, and to the entire Guatemala for the hospitality and generosity they graciously bestowed upon us during our stay in their beautiful county.

 

Without question, we’ll be seeing you…

 

 

 

Below you can see the most relevant presentations:

Andres-Iniguez1Dr. Andrés Iñiguez: “Atrial Fibrillation in Patients with Risk of Bleeding: Is there an Effective Alternative to Anticoagulation?”

 

 

 

Dr. Daniel BerrocalDr. Daniel Berrocal: “PFO Closure: When Should We Consider it?”

 

 

 

Dr. Ariel DuránDr. Ariel Durán: “Radioprotection: Current Considerations in the Peak of the Percutaneous Treatment of Heart Disease”.

 

 

 

Dr. Marcelo HalacDr. Marcelo Halac: “Heart Disease in Women: Differential Features”.

 

 

 

Dr. Marcio Montenegro: “Mitral Regurgitation: An Interventionist Clinical Approach”.

 

 

 

rodas-diazDr. Marco A. Rodas Díaz: “Dual Antiplatelet Therapy Duration in Acute Coronary Syndromes”.

 

 

Dra. Beatriz Domínguez Méndez: Castillo, Adelaida: “Post Acute Coronary Syndrome Secondary Prevention: Points to Remember”.

 

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...